273 related articles for article (PubMed ID: 1739975)
21. Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA.
Glover JN; Harrison SC
Nature; 1995 Jan; 373(6511):257-61. PubMed ID: 7816143
[TBL] [Abstract][Full Text] [Related]
22. Encounters with Fos and Jun on the road to AP-1.
Abate C; Curran T
Semin Cancer Biol; 1990 Feb; 1(1):19-26. PubMed ID: 2133107
[TBL] [Abstract][Full Text] [Related]
23. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
Ramirez-Carrozzi VR; Kerppola TK
J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
[TBL] [Abstract][Full Text] [Related]
24. Transcription. Zen and the art of Fos and Jun.
Kerppola T; Curran T
Nature; 1995 Jan; 373(6511):199-200. PubMed ID: 7816132
[No Abstract] [Full Text] [Related]
25. fos and jun interaction: the role of the leucine zipper.
Ransone LJ; Visvader J; Lamph WW; Sassone-Corsi P; Verma IM
Int J Cancer Suppl; 1989; 4():10-21. PubMed ID: 2509385
[TBL] [Abstract][Full Text] [Related]
26. Experimental identification of homodimerizing B-ZIP families in Homo sapiens.
Acharya A; Rishi V; Moll J; Vinson C
J Struct Biol; 2006 Aug; 155(2):130-9. PubMed ID: 16725346
[TBL] [Abstract][Full Text] [Related]
27. The leucine zippers of the HLH-LZ proteins Max and c-Myc preferentially form heterodimers.
Muhle-Goll C; Nilges M; Pastore A
Biochemistry; 1995 Oct; 34(41):13554-64. PubMed ID: 7577944
[TBL] [Abstract][Full Text] [Related]
28. Construction, purification, and characterization of a hybrid protein comprising the DNA binding domain of the LexA repressor and the Jun leucine zipper: a circular dichroism and mutagenesis study.
Schmidt-Dörr T; Oertel-Buchheit P; Pernelle C; Bracco L; Schnarr M; Granger-Schnarr M
Biochemistry; 1991 Oct; 30(40):9657-64. PubMed ID: 1911752
[TBL] [Abstract][Full Text] [Related]
29. High resolution NMR solution structure of the leucine zipper domain of the c-Jun homodimer.
Junius FK; O'Donoghue SI; Nilges M; Weiss AS; King GF
J Biol Chem; 1996 Jun; 271(23):13663-7. PubMed ID: 8662824
[TBL] [Abstract][Full Text] [Related]
30. A dominant negative to activation protein-1 (AP1) that abolishes DNA binding and inhibits oncogenesis.
Olive M; Krylov D; Echlin DR; Gardner K; Taparowsky E; Vinson C
J Biol Chem; 1997 Jul; 272(30):18586-94. PubMed ID: 9228025
[TBL] [Abstract][Full Text] [Related]
31. The solution structure of the leucine zipper motif of the Jun oncoprotein homodimer.
Junius FK; Weiss AS; King GF
Eur J Biochem; 1993 Jun; 214(2):415-24. PubMed ID: 8513791
[TBL] [Abstract][Full Text] [Related]
32. Noncovalent multivalent assembly of jun peptides on a leucine zipper dendrimer displaying fos peptides.
Zhou M; Ghosh I
Org Lett; 2004 Sep; 6(20):3561-4. PubMed ID: 15387548
[TBL] [Abstract][Full Text] [Related]
33. DNA bending determines Fos-Jun heterodimer orientation.
Leonard DA; Kerppola TK
Nat Struct Biol; 1998 Oct; 5(10):877-81. PubMed ID: 9783746
[TBL] [Abstract][Full Text] [Related]
34. A single site mutation in a truncated Fos protein allows it to interact with the TRE in vitro.
Nicklin MJ; Casari G
Oncogene; 1991 Jan; 6(1):173-9. PubMed ID: 1899479
[TBL] [Abstract][Full Text] [Related]
35. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer.
De Cesare D; Vallone D; Caracciolo A; Sassone-Corsi P; Nerlov C; Verde P
Oncogene; 1995 Jul; 11(2):365-76. PubMed ID: 7624151
[TBL] [Abstract][Full Text] [Related]
36. Leucine zippers of fos, jun and GCN4 dictate dimerization specificity and thereby control DNA binding.
Kouzarides T; Ziff E
Nature; 1989 Aug; 340(6234):568-71. PubMed ID: 2505081
[TBL] [Abstract][Full Text] [Related]
37. Two functionally different regions in Fos are required for the sequence-specific DNA interaction of the Fos/Jun protein complex.
Neuberg M; Schuermann M; Hunter JB; Müller R
Nature; 1989 Apr; 338(6216):589-90. PubMed ID: 2494459
[TBL] [Abstract][Full Text] [Related]
38. Parallel association of Fos and Jun leucine zippers juxtaposes DNA binding domains.
Gentz R; Rauscher FJ; Abate C; Curran T
Science; 1989 Mar; 243(4899):1695-9. PubMed ID: 2494702
[TBL] [Abstract][Full Text] [Related]
39. DNA binding and transactivation properties of Fos variants with homodimerization capacity.
Porte D; Oertel-Buchheit P; John M; Granger-Schnarr M; Schnarr M
Nucleic Acids Res; 1997 Aug; 25(15):3026-33. PubMed ID: 9304112
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of action of a dominant-negative mutant of c-Jun.
Brown PH; Chen TK; Birrer MJ
Oncogene; 1994 Mar; 9(3):791-9. PubMed ID: 8108121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
